Sign up for the QMED & MD+DI Daily newsletter.
EndoStim Inc.
Jamie Hartford 1
July 29, 2016
1 Min Read
EndoStim Inc., based in St. Louis, MO, and The Hague, The Netherlands, has developed a laparoscopically implanted stimulation system that delivers electrical impulses to treat gastroesophageal reflux disease. In May, the company secured $25 million in venture funding that will help it conduct a pivotal U.S. clinical trial.
Continue >>
[image courtesy of the company]
About the Author
You May Also Like